NRIX
Nurix TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NRIX Profile
Nurix Therapeutics, Inc.
A clinical-stage biopharmaceutical company that develops targeted protein modulation drugs
1700 Owens Street, Suite 205, San Francisco, CA 94158
--
Nurix Therapeutics, Inc., was incorporated in Delaware on August 27, 2009. The Company is a biopharmaceutical company focused on the discovery, development and commercialization of oral small molecule therapies designed to regulate cellular protein levels as new treatments for cancer and immune disorders. Leveraging their extensive expertise in E3 ligases and their proprietary DNA coding library, the company has established an integrated discovery platform, DELigase, to identify and develop new drug candidates for E3 ligases.
